Cost-Effective Interventions

Interventions are actions taken by or for individuals to reduce the risk, duration, or severity of adverse health conditions. Interventions may be population-based or personal.

DCP2 and GBD present what we know about which health interventions work for a comprehensive range of diseases, injuries, and disabilities in many different contexts. A large share of the disease burden in low- and middle-income countries is attributable to diseases and conditions for which cost-effective interventions are already known and feasible. Selecting the right intervention for a given disease and context matters a great deal. The tools on this page are designed to aid the task.

DCP2 and GBD demonstrate how decision makers could use cost-effectiveness information in combination with information on disease prevalence and avertable illness to determine which interventions should be extended and which ones should be questioned. If developing countries scale up interventions and extend health care services that are cost-effective, the impact on the disease burden could be substantial.

Select Criteria

Disease / Condition Setting Type Objective Target population

Download Results (CSV)  |  Download Full Data Set (XLS)

Condition Intervention Intervention type Intervention description Intervention setting Objective Target population Cost effectiveness (US$/DALY) Cost effectiveness estimate (US$) Cost effectiveness range (US$/DALY) Number of DALYs averted (hundreds) Number of deaths averted (hundreds) Quality of cost-effectiveness analysis evidence
Breast cancer Chemotherapy and/or tamoxifen Personal Tamoxifen and/or chemotherapy for 45-year-old premenopausal women with early-stage breast cancer; for nodepositive, node-negative, estrogenreceptor-positive, and estrogenreceptor-negative patients Local or district hospital secondary prevention Adults - 12,820-171,700 (USA) - - - 3
Breast cancer Clinical breast exam Personal Examination of the breast performed by doctors or other trained health care professionals; annually, biennially, or five yearly; for women ages 40-60 Clinic secondary prevention Adults - 7125-9907 per death prevented (India); 522-722 per LYS (India) - - - 4
Breast cancer Radiation therapy Personal Radiation therapy following mastectomy and chemotherapy for node-positive breast cancer in premenopausal women Local or district hospital secondary prevention Adults - 23,300-44,000 per QALY (USA) - - - 2
Breast cancer Screening mammography Personal Examination of the breasts performed by compressing the breast firmly between a plastic plate and an X-ray cassette that contains special X-ray film; one lifetime or biennially Clinic secondary prevention Adults - 12,262-24,493 per death prevented (India); 902-1846 per LYS (India); 2450-14,790a per YLS (Europe); 28,600-47,900 (USA) - - - 2 (USA, Europe); 4 (India)

Download Results (CSV)  |  Download Full Data Set (XLS)